CIK 0001420565 · Non-accelerated filer<br>Smaller reporting company
Rein Therapeutics, Inc.
Sign in to watch- Ticker
- RNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 134196017
- Phone
- 7378021989
- Business address
- 12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TX, 78758
- Former names
- Aileron Therapeutics, Inc., AILERON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-27 | VON RICKENBACH JOSEF H Director | Purchase | +4,500 | $1.07 | $5K | 62,514 |
| 2026-05-26 | VON RICKENBACH JOSEF H Director | Purchase | +23,190 | $1.06 | $24K | 58,014 |
| 2026-05-22 | VON RICKENBACH JOSEF H Director | Purchase | +15,950 | $1.05 | $17K | 34,824 |
| 2026-05-21 | VON RICKENBACH JOSEF H Director | Purchase | +3,420 | $1.04 | $4K | 18,874 |
| 2026-05-08 | WINDSOR JAMES BRIAN See Remarks | Grant or award · Stock Option (Right to Buy) | −150,000 | 150,000 | ||
| 2026-04-30 | WINDSOR JAMES BRIAN See Remarks | Purchase | +25,000 | $1.00 | $25K | 27,046 |
| 2025-11-14 | Voss Capital, LP 10% owner | Purchase | +104,183 | $1.22 | $128K | 926,441 |
| 2025-10-28 | Voss Capital, LP 10% owner | Purchase | +178,392 | $1.39 | $248K | 500,000 |
| 2025-10-27 | Voss Capital, LP 10% owner | Purchase | +92,642 | $1.37 | $127K | 822,258 |
| 2025-10-27 | Voss Capital, LP 10% owner | Purchase | +4,840 | $1.37 | $7K | 321,608 |
| 2025-10-24 | Voss Capital, LP 10% owner | Purchase | +30,176 | $1.39 | $42K | 729,616 |
| 2025-07-23 | Aivado Manuel Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2025-07-23 | VON RICKENBACH JOSEF H Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2025-07-23 | Musso Alan A Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2025-07-23 | Fairey William Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2025-07-23 | Ambros Reinhard J. Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2024-12-05 | WINDSOR JAMES BRIAN President and CEO | Purchase | +239 | $2.24 | $535 | 239 |
| 2024-12-05 | WINDSOR JAMES BRIAN President and CEO | Purchase | +161 | $2.25 | $362 | 161 |
| 2024-12-02 | Aivado Manuel Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2024-12-02 | Ambros Reinhard J. Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 |
Page 1 of 10 · 192 trades